Henze, Larissa http://orcid.org/0000-0001-6104-3643
Buhl, Christoph
Sandherr, Michael
Cornely, Oliver A.
Heinz, Werner J.
Khodamoradi, Yascha
Kiderlen, Til Ramon
Koehler, Philipp
Seidler, Alrun
Sprute, Rosanne
Schmidt-Hieber, Martin
von Lilienfeld-Toal, Marie
Funding for this research was provided by:
Universitätsmedizin Rostock
Article History
Received: 1 July 2021
Accepted: 19 December 2021
First Online: 7 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Larissa Henze (LH):Financing of Scientific Research: German Federal Ministry of Research and Education (BMBF).Outside the submitted work.Christoph Buhl (CB):CB has no financial or non-financial interests to disclose.Michael Sandherr (MS):Honoraria: Roche, Bristol-Myers Squibb, Novartis.Oliver A. Cornely (OAC):OAC reports grants or contracts from Amplyx, Basilea, BMBF, Cidara, DZIF, EU-DG RTD (101037867), F2G, Gilead, Matinas, MedPace, MSD, Mundipharma, Octapharma, Pfizer, Scynexis; Consulting fees from Amplyx, Biocon, Biosys, Cidara, Da Volterra, Gilead, Matinas, MedPace, Menarini, Molecular Partners, MSG-ERC, Noxxon, Octapharma, PSI, Scynexis, Seres; Honoraria for lectures from Abbott, Al-Jazeera Pharmaceuticals, Astellas, Grupo Biotoscana/United Medical/Knight, Hikma, MedScape, MedUpdate, Merck/MSD, Mylan, Pfizer; Payment for expert testimony from Cidara; Participation on a Data Safety Monitoring Board or Advisory Board from Actelion, Allecra, Cidara, Entasis, IQVIA, Jannsen, MedPace, Paratek, PSI, Shionogi; A pending patent currently reviewed at the German Patent and Trade Mark Office; Other interests from DGHO, DGI, ECMM, ISHAM, MSG-ERC, Wiley.Werner J. Heinz (WJH):Financing of scientific research: MSD Sharp & Dohme/Merck and Pfizer;Other Financial Relationships: serves on the speakers’ bureaus of Abbvie, AstraZeneca, Bristol-Myers Squibb, Gilead Sciences, Janssen, MSD Sharp & Dohme, and Pfizer; received travel grants from Abbvie, Alexion, Astellas, Lilly, MSD Sharp & Dohme, Novartis and Pfizer.Yascha Khodamoradi (YK):Other Financial Relationships: speaker’s fee and travel grant from GILEAD Science, MSD Sharp & Dome.Til Ramon Kiderlen (TRK):Advisory Role: GSK.Honoraria: Pfizer, GSK.Financing of scientific research: Pfizer.Philipp Koehler (PK):Advisory Role and/or Honoraria: Akademie für Infektionsmedizin e.V., Ambu GmbH, Astellas Pharma, European Confederation of Medical Mycology, Gilead Sciences, GPR Academy Ruesselsheim, MSD Sharp & Dohme GmbH, Noxxon N.V., University Hospital, LMU Munich;Financing of scientific research: German Federal Ministry of Research and Education and the State of North Rhine-Westphalia, Germany;Non-financial scientific grants: Miltenyi Biotec GmbH, Bergisch Gladbach, Germany, the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.Outside the submitted work.Alrun Seidler (AS):AS has no financial or non-financial interests to disclose.Rosanne Sprute (RS):RS has no financial or non-financial interests to disclose.Martin Schmidt-Hieber (MSH):Advisory Role or Expert Testimony (no personal fee): Celgene GmbH, Amgen, Kite/Pharma Gilead, Sanofi;Other Financial Relationships: financial support of educational meetings at the Carl-Thiem-Klinikum Cottbus by Janssen-Cilag GmbH, Takeda Pharma Vertrieb GmbH & Co. KG, Novartis Pharma Oncology, Pfizer Pharma GmbH, Roche Pharma AG, Vifor Pharma Deutschland GmbH, Celgene GmbH.Marie von Lilienfeld-Toal (MvL):Advisory Role or Expert Testimony: Celgene, Gilead, Oncopeptides, MSD, 4DPharma, Janssen, Shionogi, Pfizer.Honoraria: Celgene, Gilead, Chugai, Janssen, Novartis, Amgen, Takeda, BMS, Medac, Oncopeptides, Merck, CDDF, Abbvie, AstraZeneca, Pfizer.Financing of Scientific Research: German Federal Ministry of Research and Education, Deutsche Jose Carreras Leukämie-Stiftung, IZKF Jena, DFG (German Research Foundation), Novartis, Gilead, Deutsche Krebshilfe, Celgene, Oncopeptides.Other Financial Relationships (travel grants): Janssen, Celgene.